Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler
Condition: Asthma Intervention: Device: RP - TA Sponsor: Elpen Pharmaceutical Co. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Condition: Asthma Interventions: Drug: Montelukast; Drug: Fluticasone Sponsors: Brigham and Women's Hospital; National Institute on Aging (NIA); Rutgers University; Johns Hopkins University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials
Efficacy and Safety Study of Fluticasone/Salmeterol Administered With Elpenhaler
Condition: Asthma Intervention: Device: RP - TA Sponsor: Elpen Pharmaceutical Co. Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Montelukast vs Fluticasone
Condition: Asthma Interventions: Drug: Montelukast; Drug: Fluticasone Sponsors: Brigham and Women's Hospital; National Institute on Aging (NIA); Rutgers University; Johns Hopkins University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 14, 2022 Category: Research Source Type: clinical trials